Targeted Treatment Strategies and Medication Management for Rheumatic Diseases During Pregnancy and Lactation: A Comprehensive Review
Rheumatic Diseases in Pregnancy and Lactation
Abstract views: 68
/ 
PDF downloads: 75
DOI:
https://doi.org/10.5281/zenodo.13955951Keywords:
Immune-mediated rheumatic diseases, Pregnancy, Preconception Counseling, Medication Safety, Autoimmune Disorders in PregnancyAbstract
Pregnancy in women with immune-mediated rheumatic diseases poses significant challenges, including risks for both maternal and fetal adverse outcomes. This comprehensive review addresses the management of immune-mediated rheumatic diseases during pregnancy and lactation, focusing on medication strategies and treatment protocols to optimize pregnancy outcomes. The continuation or cessation of medications, including biologics and immunosuppressants, is a critical factor in managing disease activity while minimizing fetal risks. The review also explores the use of assisted reproductive technologies, fertility preservation methods for patients undergoing gonadotoxic treatments, and hormone replacement therapy. Additionally, the management of pregnancy in patients with conditions such as systemic lupus erythematosus, antiphospholipid syndrome, and Sjögren’s syndrome is discussed. Key recommendations from the American College of Rheumatology 2020 guidelines are provided, outlining best practices for medication use during pre-conception, pregnancy, and postpartum care. The review underscores the importance of individualized treatment plans and interdisciplinary collaboration to ensure favorable outcomes for both mother and child.
References
Mitchell K, Kaul M, Clowse ME. The management of rheumatic diseases in pregnancy. Scand J Rheumatol. 2010 Mar;39(2):99-108. doi: 10.3109/03009740903449313.
Alkhodier AA, Alsaif AS, Alqntash NH, Alanazi RB, Alotaibi G, Alrashid A. Pregnancy and Inflammatory Rheumatological Diseases: A Single-Center Retrospective Cohort Study. Cureus. 2023;15(10):e47277. Published 2023 Oct 18. doi:10.7759/cureus.47277
Gamba A, Zen M, Depascale R, et al. Modern Management of Pregnancy in Systemic Lupus Erythematosus: From Prenatal Counseling to Postpartum Support. J Clin Med. 2024;13(12):3454. Published 2024 Jun 13. doi:10.3390/jcm13123454
Fischer-Betz R, Specker C. Pregnancy in systemic lupus erythematosus and antiphospholipid syndrome. Best Pract Res Clin Rheumatol. 2017;31(3):397-414. doi:10.1016/j.berh.2017.09.011
Helland Y, Kjeken I, Steen E, Kvien TK, Hauge MI, Dagfinrud H. Rheumatic diseases and sexuality: Disease impact and self-management strategies. Arthritis Care Res (Hoboken). 2011;63(5):743-750. doi:10.1002/acr.20424
Østensen M. Sexual and reproductive health in rheumatic disease. Nat Rev Rheumatol. 2017;13(8):485-493. doi:10.1038/nrrheum.2017.102
Klein CE. Effects of Chemotherapy on Gonadal Function. In: Kufe DW, Pollock RE, Weichselbaum RR, et al., editors. Holland-Frei Cancer Medicine. 6th edition. Hamilton (ON): BC Decker; 2003. Available from: https://www.ncbi.nlm.nih.gov/books/NBK13402/
Jain V, Gordon C. Managing pregnancy in inflammatory rheumatological diseases. Arthritis Res Ther. 2011 Feb 25;13(1):206. doi: 10.1186/ar3227.
Dao KH, Bermas BL. Systemic Lupus Erythematosus Management in Pregnancy. Int J Womens Health. 2022 Feb 15;14:199-211. doi: 10.2147/IJWH.S282604.
Kavanaugh A, Cush JJ, Ahmed MS, et al. Proceedings from the American College of Rheumatology Reproductive Health Summit: the management of fertility, pregnancy, and lactation in women with autoimmune and systemic inflammatory diseases [published correction appears in Arthritis Care Res (Hoboken). 2015 May;67(5):738]. Arthritis Care Res (Hoboken). 2015;67(3):313-325. doi:10.1002/acr.22516
Jethwa H, Lam S, Smith C, Giles I. Does Rheumatoid Arthritis Really Improve During Pregnancy? A Systematic Review and Metaanalysis. J Rheumatol. 2019;46(3):245-250. doi:10.3899/jrheum.180226
Secher AEP, Granath F, Glintborg B, Rom A, Hetland ML, Hellgren K. Risk of pre-eclampsia and impact of disease activity and antirheumatic treatment in women with rheumatoid arthritis, axial spondylarthritis and psoriatic arthritis: a collaborative matched cohort study from Sweden and Denmark. RMD Open. 2022 Nov;8(2):e002445. doi: 10.1136/rmdopen-2022-002445.
Hamroun S, Hamroun A, Bigna JJ, Allado E, Förger F, Molto A. Fertility and pregnancy outcomes in women with spondyloarthritis: a systematic review and meta-analysis. Rheumatology (Oxford). 2022;61(4):1314-1327. doi:10.1093/rheumatology/keab589
Gamba A, Zen M, Depascale R, Calligaro A, Gatto M, Iaccarino L, Doria A. Modern Management of Pregnancy in Systemic Lupus Erythematosus: From Prenatal Counseling to Postpartum Support. J Clin Med. 2024 Jun 13;13(12):3454. doi: 10.3390/jcm13123454.
Killian M, van Mens TE. Risk of Thrombosis, Pregnancy Morbidity or Death in Antiphospholipid Syndrome. Front Cardiovasc Med. 2022 Mar 1;9:852777. doi: 10.3389/fcvm.2022.852777.
Gupta S, Gupta N. Sjögren Syndrome and Pregnancy: A Literature Review. Perm J. 2017;21:16-047. doi: 10.7812/TPP/16-047. Epub 2016 Nov 9.
Betelli M, Breda S, Ramoni V, et al. Pregnancy in systemic sclerosis. J Scleroderma Relat Disord. 2018;3(1):21-29. doi:10.1177/2397198317747440
Sandoval-Valdez D, Silveira LH, Rodríguez E. Cardiovascular risk in the postnatal life of children born to women with systemic lupus erythematous. Arch Cardiol Mex. 2022 Oct 21;92(4):522-529. doi: 10.24875/ACM.21000063.
Di Ludovico A, Rinaldi M, Mainieri F, Di Michele S, Girlando V, Ciarelli F, La Bella S, Chiarelli F, Attanasi M, Mauro A, Bizzi E, Brucato A, Breda L. Molecular Mechanisms of Fetal and Neonatal Lupus: A Narrative Review of an Autoimmune Disease Transferal across the Placenta. Int J Mol Sci. 2024 May 10;25(10):5224. doi: 10.3390/ijms25105224.
Morel N, Georgin-Lavialle S, Levesque K, et al. « Lupus néonatal » : revue de la littérature [Neonatal lupus syndrome: Literature review]. Rev Med Interne. 2015;36(3):159-166. doi:10.1016/j.revmed.2014.07.013
Di Prima FA, Valenti O, Hyseni E, Giorgio E, Faraci M, Renda E, De Domenico R, Monte S. Antiphospholipid Syndrome during pregnancy: the state of the art. J Prenat Med. 2011 Apr;5(2):41-53.
D'Ippolito S, Barbaro G, Paciullo C, Tersigni C, Scambia G, Di Simone N. Antiphospholipid Syndrome in Pregnancy: New and Old Pathogenetic Mechanisms. Int J Mol Sci. 2023 Feb 6;24(4):3195. doi: 10.3390/ijms24043195.
Lian XJ, Fan L, Xia X, Huang XM, Ye HJ, Yu XQ, Chen HT, Chen W. Fetal and maternal outcome in patients with active lupus nephritis: comparison between new-onset and pre-existing lupus nephritis. BMC Nephrol. 2021 Dec 21;22(1):419. doi: 10.1186/s12882-021-02633-2.
Hladunewich MA. Chronic Kidney Disease and Pregnancy. Semin Nephrol. 2017;37(4):337-346. doi:10.1016/j.semnephrol.2017.05.005
Dvořák J, Koucký M, Jančová E, Mysliveček M, Tesař V, Pařízek A. Chronic kidney disease and pregnancy outcomes [published correction appears in Sci Rep. 2021 Dec 30;11(1):24535. doi: 10.1038/s41598-021-04142-6]. Sci Rep. 2021;11(1):21299. Published 2021 Oct 29. doi:10.1038/s41598-021-00670-3
Lockshin MD. Assisted reproductive technologies for women with rheumatic AID. Best Pract Res Clin Obstet Gynaecol. 2020;64:85-96. doi:10.1016/j.bpobgyn.2019.10.002
Reggia R, Andreoli L, Sebbar H, Canti V, Ceccarelli F, Favaro M, Hoxha A, Inversetti A, Larosa M, Ramoni V, Caporali R, Conti F, Doria A, Montecucco C, Rovere-Querini P, Ruffatti A, Valesini G, Zatti S, Fallo L, Lojacono A, Tincani A. An observational multicentre study on the efficacy and safety of assisted reproductive technologies in women with rheumatic diseases. Rheumatol Adv Pract. 2019 Feb 22;3(1):rkz005. doi: 10.1093/rap/rkz005.
Fu J, Tomlinson G, Feig DS. Increased risk of major congenital malformations in early pregnancy use of angiotensin-converting-enzyme inhibitors and angiotensin-receptor-blockers: a meta-analysis. Diabetes Metab Res Rev. 2021;37(8):e3453. doi:10.1002/dmrr.3453
Bütikofer L, Varisco PA, Distler O, et al. ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis-a EUSTAR analysis. Arthritis Res Ther. 2020;22(1):59. Published 2020 Mar 24. doi:10.1186/s13075-020-2141-2
Clowse MEB, Eudy AM, Balevic S, Sanders-Schmidler G, Kosinski A, Fischer-Betz R, Gladman DD, Molad Y, Nalli C, Mokbel A, Tincani A, Urowitz M, Bay C, van Noord M, Petri M. Hydroxychloroquine in the pregnancies of women with lupus: a meta-analysis of individual participant data. Lupus Sci Med. 2022 Mar;9(1):e000651. doi: 10.1136/lupus-2021-000651.
Lee EE, Jun JK, Lee EB. Management of Women with Antiphospholipid Antibodies or Antiphospholipid Syndrome during Pregnancy. J Korean Med Sci. 2021 Jan 25;36(4):e24. doi: 10.3346/jkms.2021.36.e24.
Leroy C, Rigot JM, Leroy M, Decanter C, Le Mapihan K, Parent AS, Le Guillou AC, Yakoub-Agha I, Dharancy S, Noel C, Vantyghem MC. Immunosuppressive drugs and fertility. Orphanet J Rare Dis. 2015 Oct 21;10:136. doi: 10.1186/s13023-015-0332-8.
Koren G, Florescu A, Costei AM, Boskovic R, Moretti ME. Nonsteroidal antiinflammatory drugs during third trimester and the risk of premature closure of the ductus arteriosus: a meta-analysis. Ann Pharmacother. 2006;40(5):824-829. doi:10.1345/aph.1G428
Beltagy A, Aghamajidi A, Trespidi L, Ossola W, Meroni PL. Biologics During Pregnancy and Breastfeeding Among Women With Rheumatic Diseases: Safety Clinical Evidence on the Road. Front Pharmacol. 2021 Feb 11;12:621247. doi: 10.3389/fphar.2021.621247.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 Mehmet Akif Baltaci, Melih Pamukcu
This work is licensed under a Creative Commons Attribution 4.0 International License.
The journal is licensed under a 